Free Trial

Galectin Therapeutics (GALT) Insider Trading & Ownership

$2.24
-0.12 (-5.08%)
(As of 07/12/2024 ET)

Galectin Therapeutics (NASDAQ:GALT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
52.70%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$18,115.42
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$65,248.38
Get GALT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Galectin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GALT Insider Buying and Selling by Quarter

Galectin Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/30/2024Richard A Jr. ZordaniDirectorBuy1,000$3.52$3,520.00  
4/24/2024Joel LewisCEOBuy1,000$3.39$3,390.00  
4/22/2024James C CzirrMajor ShareholderSell21,323$3.06$65,248.38  
4/22/2024Kevin D FreemanDirectorBuy2,500$2.98$7,450.00  
1/16/2024Kary EldredDirectorBuy500$1.79$895.00  
7/19/2023Kary EldredDirectorBuy1,598$1.79$2,860.42  
(Data available from 1/1/2013 forward)

GALT Insider Trading Activity - Frequently Asked Questions

Who is on Galectin Therapeutics's Insider Roster?

The list of insiders at Galectin Therapeutics includes Elissa J Schwartz, Fund L.P. 10X, Jack W Callicutt, James C Czirr, Joel Lewis, Kary Eldred, Kevin D Freeman, and Richard A Jr. Zordani. Learn more on insiders at GALT.

What percentage of Galectin Therapeutics stock is owned by insiders?

52.70% of Galectin Therapeutics stock is owned by insiders. Learn more on GALT's insider holdings.

Which Galectin Therapeutics insiders have been buying company stock?

The following insiders have purchased GALT shares in the last 24 months: Jack W Callicutt ($5,280.00), Joel Lewis ($4,910.00), Kary Eldred ($6,788.42), Kevin D Freeman ($21,550.00), and Richard A Jr. Zordani ($16,020.00).

How much insider buying is happening at Galectin Therapeutics?

Insiders have purchased a total of 28,898 GALT shares in the last 24 months for a total of $54,548.42 bought.

Which Galectin Therapeutics insiders have been selling company stock?

The following insider sold GALT shares in the last 24 months: James C Czirr ($65,248.38).

How much insider selling is happening at Galectin Therapeutics?

Insiders have sold a total of 21,323 Galectin Therapeutics shares in the last 24 months for a total of $65,248.38 sold.


This page (NASDAQ:GALT) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners